However, VHL wild-type (VHL-wt) ccRCC at advanced stages has a poor prognosis because of distal metastasis and less targeted-therapy effectiveness, emphasizing the urgent need to clarify the underlying mechanisms and find better therapeutic targets. The gene discussed is VHL; the disease is nonpapillary renal cell carcinoma.